*
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a prior cover page.
|
CUSIP No. M40527109
|
|
13G
|
|
Page 2 of 7 Pages
|
1
|
|
NAME OF REPORTING PERSON
D.N.A Biomedical Solutions Ltd.
|
||
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ☐
(b) ☐
|
||
3
|
|
SEC USE ONLY
|
||
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
---
|
||
6
|
SHARED VOTING POWER
3,256,630 (*)
|
|||
7
|
SOLE DISPOSITIVE POWER
---
|
|||
8
|
SHARED DISPOSITIVE POWER
3,256,630 (*)
|
|||
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,256,630 (*)
|
||
10
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
||
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
18.23% (*) (**)
|
||
12
|
|
TYPE OF REPORTING PERSON
CO
|
CUSIP No. M40527109
|
|
13G
|
|
Page 3 of 7 Pages
|
1
|
|
NAME OF REPORTING PERSON
Zeev Bronfeld
|
|||
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ☐
(b) ☐
|
|||
3
|
|
SEC USE ONLY
|
|||
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
SOLE VOTING POWER
---
|
||
|
6
|
SHARED VOTING POWER
3,290,268 (*)
|
|||
|
7
|
SOLE DISPOSITIVE POWER
---
|
|||
|
8
|
SHARED DISPOSITIVE POWER
3,290,268 (*)
|
|||
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,290,268 (*)
|
|||
10
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐
|
|||
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
18.42% (*) (**)
|
|||
12
|
|
TYPE OF REPORTING PERSON
IN
|
Item 1(a). | Name of Issuer |
Item 1(b).
|
Address of Issuer’s Principal Executive Offices
|
Item 2(a).
|
Name of Person Filing
|
Item 2(b).
|
Address of Principal Business Office or, if none, Residence
|
Item 2(c).
|
Citizenship
|
Item 2(d).
|
Title of Class of Securities
|
Item 2(e).
|
CUSIP Number
|
Item 3.
|
Not applicable
|
Item 4.
|
Ownership
|
(a).
|
Amount beneficially owned
|
(b).
|
Percent of Class
See row 11 of cover page of each reporting person.
|
(c).
|
Number of shares as to which such person has:
|
|
(i)
|
sole power to vote or to direct the vote: see row 5 of cover page of each reporting person
|
|
(ii)
|
shared power to vote or to direct the vote: see row 6 of cover page of each reporting person
|
|
(iii)
|
sole power to dispose or to direct the disposition of: see row 7 of cover page of each reporting person
|
|
(iv)
|
shared power to dispose or to direct the disposition of: see row 8 of cover page of each reporting person
|
Item 5.
|
Ownership of Five Percent or Less of a Class
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
Item 7.
|
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
|
Item 8.
|
Identification and Classification of Members of the Group
|
Item 9.
|
Notice of Dissolution of Group
|
Item 10.
|
Certification
|
Zeev Bronfeld
|
D.N.A Biomedical Solutions Ltd.
|
|
||||
By: /s/ Zeev Bronfeld
|
By: /s/ Tony Klein
Name: Tony Klein
|
|
|
|||
|
Title: CFO
|
|
|